Biktarvy, formally known as bictegravir sulfate, represents a effective single-tablet regimen for treating HIV infection. This drug integrates three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It works by inhibiting the the viral ability to replicate within the body, considerably decreasing the viral burden. F